This paper was originally published by J. Javier Hernandez, Michael Pryszlak, Lindsay Smith, Connor Yanchus, Naheed Kurji, Vijay M. Shahani and […]
Litigation related to drug patents, whether it be direct patent challenges, contract disputes, or other cases, can provide direct intelligence
Disclosure: the majority of the companies mentioned below are, or have been, clients of DrugPatentWatch Drug patent litigation can be
Pharmacists find themselves caught in a precarious position, sandwiched between the escalating costs of prescription drugs and the increasing demands
How Pharmacists Are Trapped in the Middle of Drug Price Wars Read Post »
One powerful tool that savvy industry professionals use to gain a competitive edge is the analysis of tentative drug approvals.
How to Use Tentative Drug Approvals to Anticipate Generic Entry Read Post »
This paper was originally published by Rishi J Desai, Ameet Sarpatwari, Sara Dejene, Nazleen F Khan, Joyce Lii, James R Rogers, Sarah K Dutcher, Saeid Raofi, Justin Bohn,
This paper was originally published by Martin Schiestl, Markus Zabransky, and Fritz Sörgel in Drug Des Devel Ther. 2017; 11: 1509–1515 under
Ten years of biosimilars in Europe: development and evolution of the regulatory pathways Read Post »
What can we build for you? Do you have special business intelligence needs? Let us apply our industry expertise and
Make better decisions with advanced biopharmaceutical business intelligence Read Post »
The Current Landscape of Drug Innovation The pharmaceutical industry stands at a crossroads, facing unprecedented challenges and opportunities. With the
Get fresh news and insights, drug patent expirations & more…
